MiPT: Difference between revisions

(One intermediate revision by one other user not shown)

Line 2:

'''N-Methyl-N-isopropyltryptamine''' (also known as '''MiPT''') is a lesser-known [[psychoactive class::psychedelic]] substance of the [[chemical class::tryptamine]] class ~~that produces [[psychedelic]] effects when [[routes of administration|administered]]~~. It is structurally related to ~~tryptamines like~~ [[DMT]], [[DiPT]], ~~and~~ [[~~MET~~]]~~, although it is reported to produce qualitatively different effects. Its effects are generally described as mild, indistinct~~, and ~~highly variable between users. In contrast to many related tryptamines, it is able to be taken~~ [[~~orally~~]].

'''N-Methyl-N-isopropyltryptamine''' (also known as '''MiPT''') is a lesser-known [[psychoactive class::psychedelic]] substance of the [[chemical class::tryptamine]] class. It is structurally related to [[DMT]], along with other analogs such as [[DiPT]], [[MPT]], and [[MET]].

MiPT was first synthesized and investigated by [[Alexander Shulgin]] and described in his book [[TiHKAL]] ("Tryptamines I Have Known and Loved"). In the commentary, Shulgin notes that "there is almost a total lack of visual phenomena... no wave-forms, color distortion or object shape changes, and no eyes-closed imagery, unlike most N,N-disubstituted tryptamines."<ref name="TiHKAL">{{cite book|title=TiHKAL: The Continuation|title-link=TiHKAL|last1=Shulgin|first1=Alexander|last2=Shulgin|first2=Ann|author-link1=Alexander Shulgin|year=1997|publisher=Transform Press|location=United States|isbn=0-9630096-9-9|oclc=38503252|chapter-url=https://erowid.org/library/books_online/tihkal/tihkal47.shtml|chapter=#47. MIPT}}</ref>

Subjective effects include hallucinatory states, [[time distortion]], [[conceptual thinking]], [[euphoria]], and [[ego loss]]. Its effects are generally described as mild, indistinct, and highly variable between users. In contrast to many related tryptamines, it is able to be taken [[orally]].

Today, MiPT remains relatively uncommon and is either used as a recreational or an [[entheogenic]] substance. It has been distributed online as a [[research chemical]]. Very little data exists about the pharmacological properties, metabolism, and toxicity of MiPT in humans, and it has little history of human usage.

Line 106:

Line 108:

*'''Switzerland''': MiPT is not controlled under Buchstabe A, B, C and D. It could be considered legal.<ref>{{cite web|url=https://www.admin.ch/opc/de/classified-compilation/20101220/index.html|title=Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien|publisher=Bundeskanzlei [Federal Chancellery of Switzerland]|access-date=January 1, 2020|language=de}}</ref>

*'''United Kingdom''': MiPT is a Class A controlled substance in the United Kingdom as a result of the tryptamine catch-all clause.<ref>{{cite web|title=Part I: Class A Drugs|url=http://www.legislation.gov.uk/ukpga/1971/38/schedule/2/part/I|work="Misuse of Drugs Act 1971"|access-date=January 7, 2020|publisher=UK Government}}</ref>

*'''United States''': MiPT is ~~unscheduled~~ in the ~~United States~~.

*'''United States''': MiPT is considered a schedule 1 controlled substance as a positional isomer of Diethyltryptamine (DET). MiPT is specifically mentioned by name in the DEA Orange Book<ref>{{cite web|title=Orange Book - List of Controlled Substances and Regulated Chemicals|url=https://www.deadiversion.usdoj.gov/schedules/orangebook/orangebook.pdf|access-date=September 17, 2023|publisher=Drug Enforcement Adminitration}}</ref>, which lists all the controlled substances and other regulated chemicals in the US.

==See also==

@@ Line 2: / Line 2: @@
 {{SubstanceBox/MiPT}}
-'''N-Methyl-N-isopropyltryptamine''' (also known as '''MiPT''') is a lesser-known [[psychoactive class::psychedelic]] substance of the [[chemical class::tryptamine]] class that produces [[psychedelic]] effects when [[routes of administration|administered]]. It is structurally related to tryptamines like [[DMT]], [[DiPT]], and [[MET]], although it is reported to produce qualitatively different effects. Its effects are generally described as mild, indistinct, and highly variable between users. In contrast to many related tryptamines, it is able to be taken [[orally]].
+'''N-Methyl-N-isopropyltryptamine''' (also known as '''MiPT''') is a lesser-known [[psychoactive class::psychedelic]] substance of the [[chemical class::tryptamine]] class. It is structurally related to [[DMT]], along with other analogs such as [[DiPT]], [[MPT]], and [[MET]].
 MiPT was first synthesized and investigated by [[Alexander Shulgin]] and described in his book [[TiHKAL]] ("Tryptamines I Have Known and Loved"). In the commentary, Shulgin notes that "there is almost a total lack of visual phenomena... no wave-forms, color distortion or object shape changes, and no eyes-closed imagery, unlike most N,N-disubstituted tryptamines."<ref name="TiHKAL">{{cite book|title=TiHKAL: The Continuation|title-link=TiHKAL|last1=Shulgin|first1=Alexander|last2=Shulgin|first2=Ann|author-link1=Alexander Shulgin|year=1997|publisher=Transform Press|location=United States|isbn=0-9630096-9-9|oclc=38503252|chapter-url=https://erowid.org/library/books_online/tihkal/tihkal47.shtml|chapter=#47. MIPT}}</ref>
+Subjective effects include hallucinatory states, [[time distortion]], [[conceptual thinking]], [[euphoria]], and [[ego loss]]. Its effects are generally described as mild, indistinct, and highly variable between users. In contrast to many related tryptamines, it is able to be taken [[orally]].
 Today, MiPT remains relatively uncommon and is either used as a recreational or an [[entheogenic]] substance. It has been distributed online as a [[research chemical]]. Very little data exists about the pharmacological properties, metabolism, and toxicity of MiPT in humans, and it has little history of human usage.
@@ Line 106: / Line 108: @@
 *'''Switzerland''': MiPT is not controlled under Buchstabe A, B, C and D. It could be considered legal.<ref>{{cite web|url=https://www.admin.ch/opc/de/classified-compilation/20101220/index.html|title=Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien|publisher=Bundeskanzlei [Federal Chancellery of Switzerland]|access-date=January 1, 2020|language=de}}</ref>
 *'''United Kingdom''': MiPT is a Class A controlled substance in the United Kingdom as a result of the tryptamine catch-all clause.<ref>{{cite web|title=Part I: Class A Drugs|url=http://www.legislation.gov.uk/ukpga/1971/38/schedule/2/part/I|work="Misuse of Drugs Act 1971"|access-date=January 7, 2020|publisher=UK Government}}</ref>
-*'''United States''': MiPT is unscheduled in the United States.
+*'''United States''': MiPT is considered a schedule 1 controlled substance as a positional isomer of Diethyltryptamine (DET). MiPT is specifically mentioned by name in the DEA Orange Book<ref>{{cite web|title=Orange Book - List of Controlled Substances and Regulated Chemicals|url=https://www.deadiversion.usdoj.gov/schedules/orangebook/orangebook.pdf|access-date=September 17, 2023|publisher=Drug Enforcement Adminitration}}</ref>, which lists all the controlled substances and other regulated chemicals in the US.
 ==See also==